Skip to main content
Equibles

Balyasny Asset Management L.P.

Position in GMAB — Genmab A/S

CIK 1218710 Chicago, IL
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$11,684,411 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Derivatives in GMAB

reported options exposure · as of Jun 30, 2026
CallValue
$3,876,017
CallShares
141,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 1,665,102 $221,008,988
2 INSM
INSMED Inc
 1,326,430 $141,423,966
3 BBIO
BridgeBio Pharma, Inc.
 1,230,052 $91,614,272
4 ABVX
Abivax S.A.
 603,840 $80,467,718
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 145,005 $72,028,333
6 TNGX
Tango Therapeutics, Inc.
 2,016,379 $63,032,007
7 CYTK
Cytokinetics Inc
 711,676 $60,627,678
8 BMRN
Biomarin Pharmaceutical Inc
 1,054,613 $60,344,955

All Filings in GMAB

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,876,017 141,100
2025-12-31 $11,684,411 379,364
2024-09-30 $5,184,723 212,663
2023-09-30 $936,489 26,552
2023-06-30 $288,457 7,589
2022-12-31 $1,059,754 25,006
2022-09-30 $1,619,962 50,419
2020-09-30 $534,176 14,591
2020-03-31 $491,163 23,179